Browsing Category
Pharma Industry News
4763 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Zydus Lifesciences gains FDA aproval for Chlorpromazine Hydrochloride Injection
In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has…
March 14, 2024
Eris Lifesciences acquires Biocon Biologics’ branded formulation business for Rs 1,242cr
In a strategic move that reshapes the landscape of India’s injectables market, Eris Lifesciences Ltd., a leading player…
March 14, 2024
EC authorizes Pfizer’s PREVENAR 20 vaccine for pediatric Use
In a landmark decision, Pfizer Inc. (NYSE: PFE) has been granted marketing authorization by the European Commission (EC)…
March 14, 2024
Takeda announces positive results for mezagitamab in Phase 2 ITP study
Takeda Pharmaceutical Company Limited has disclosed favorable top-line outcomes from a Phase 2, randomized, double-blind, placebo-controlled trial, assessing…
March 14, 2024
Poseida Therapeutics gets FDA orphan drug designation for P-BCMA-ALLO1 in multiple myeloma
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a trailblazer in the field of clinical-stage cell and gene therapy, has achieved…
March 14, 2024
Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible
In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name…
March 13, 2024
Nirma Limited acquires majority stake in Glenmark Life Sciences in strategic expansion into pharmaceuticals
In a significant move within the pharmaceutical and life sciences sector, Nirma Limited, a conglomerate known for its…
March 12, 2024
AstraZeneca Pharma India, Mankind Pharma announce distribution partnership for asthma medication Symbicort
AstraZeneca Pharma India Limited (AstraZeneca India) and Mankind Pharma Limited have embarked on a strategic collaboration for the…
March 12, 2024
Amylyx Pharmaceuticals’ AMX0035 misses primary and secondary endpoints in ALS study
Cambridge, Massachusetts-based Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a key player in the pharmaceutical industry, announced today the top-line…
March 10, 2024
LEO Pharma showcases promising results from DELTA 3 trial at AAD Congress
In a significant development within the field of medical dermatology, LEO Pharma A/S, a global leader renowned for…
March 10, 2024